Birmingham-led Trial Shows Promise for Dendritic Cell Vaccine in Liver Cancer Treatment
Patients with intermediate-stage primary liver cancer have shown significantly improved outcomes in a groundbreaking clinical trial led by researchers at the University of Birmingham. The ImmunoTACE study, funded by the […]





